Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
Clinical trial NCT04251910 · COMPLETED
Trial details
- NCT number
- NCT04251910
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-27
- Primary completion
- 2022-01-24
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.